Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion type Assertion NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_head.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion wasGeneratedBy ECO_0000203 NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_provenance.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion wasDerivedFrom lhgdn-20090331 NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_provenance.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion SIO_000772 14507635 NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_provenance.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion evidence source_evidence_literature NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_provenance.
- NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend the potential options for therapeutic targeting of kinases in the treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201521.RA_6nCYxl17-1DU_HG3UwfzK3zr9X9aB5-pRgw4QMVgaU130_provenance.